{"id":46344,"date":"2023-11-24T09:47:00","date_gmt":"2023-11-24T09:47:00","guid":{"rendered":"http:\/\/b8165a564c48ecaaa2f29d8a79c34d21"},"modified":"2024-11-03T15:12:20","modified_gmt":"2024-11-03T15:12:20","slug":"esmo-asia-congress-2023-1-3-december-2023-singapore","status":"publish","type":"post","link":"https:\/\/ogkologos.com\/en\/esmo-asia-congress-2023-1-3-december-2023-singapore\/","title":{"rendered":"ESMO Asia Congress 2023, 1-3 December 2023, Singapore"},"content":{"rendered":"<p>LUGANO, Switzerland \u2013 The&nbsp;<a href=\"https:\/\/www.esmo.org\/meeting-calendar\/esmo-asia-congress-2023\" class>ESMO Asia Congress 2023<\/a>&nbsp;is the annual meeting to present and discuss the latest scientific and clinical advances across the entire field of oncology, of relevance at a global level and specifically for the Asia-Pacific region. The event will be held in person in Singapore from 1 to 3 December 2023.<\/p>\n<p>Distinguished international experts, key opinion leaders, and Asia-Pacific oncology associations will be at the forefront to cover this year\u2019s scientific <a href=\"https:\/\/cslide.ctimeetingtech.com\/asia2023\/attendee\/confcal\/session\/calendar\/2023-12-01\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">programme<\/a>, with sessions ranging from state-of-the-art multidisciplinary oncology care to the latest developments against the most prevalent cancer types in the region.<\/p>\n<h3>Programme highlights<\/h3>\n<ul>\n<li>New insights into the multifaced applications of liquid biopsies: from early detection and management of cancer to underpinning national screening programmes (<a href=\"https:\/\/cslide.ctimeetingtech.com\/asia2023\/attendee\/confcal\/show\/session\/48\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">Mini Oral session<\/a> \u2013 LBA2, 56MO and <a href=\"https:\/\/cslide.ctimeetingtech.com\/asia2023\/attendee\/confcal\/session\/list?q=5P&amp;r=st%7E8\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">Poster viewing session<\/a> \u2013 12P, 407P, 410P, 415P)<\/li>\n<li>Asian studies in the expanding role of real-world data in oncology to obtaining insights on (rare) immune related toxicities (<a href=\"https:\/\/cslide.ctimeetingtech.com\/asia2023\/attendee\/confcal\/session\/list?r=st%7E6%7E%7Ept%7E32\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">Mini Oral session<\/a> \u2013 433MO, 434MO)<\/li>\n<li>Multimodal data integration for providing novel biomarker and personalised care in breast cancer (<a href=\"https:\/\/cslide.ctimeetingtech.com\/asia2023\/attendee\/confcal\/session\/list?q=1MO&amp;r=st%7E6\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">Mini Oral session<\/a> \u2013 1MO, 2MO, 3MO)<\/li>\n<li>Lifestyle changes, air pollution and screening programmes: what are the policy options to improve primary, secondary &amp; tertiary cancer prevention in the Asia &amp; Pacific region? (<a href=\"https:\/\/cslide.ctimeetingtech.com\/asia2023\/attendee\/confcal\/session\/list?q=Europe%3A\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">Educational session<\/a>)<\/li>\n<li>Results in the Asian populations of global phase 3 trials in:\n<ul>\n<li>resected, early-stage ALK+ non-small cell lung cancer <a href=\"https:\/\/cslide.ctimeetingtech.com\/asia2023\/attendee\/confcal\/presentation\/list?q=LBA1\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">(LBA1<\/a> \u2013 ALINA, Asia subgroup analysis)<\/li>\n<li>advanced or metastatic urothelial cancer and selected fibroblast growth factor receptor alterations (<a href=\"https:\/\/cslide.ctimeetingtech.com\/asia2023\/attendee\/confcal\/presentation\/list?q=208O\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">208O<\/a> \u2013 THOR, Asia subgroup analysis)<\/li>\n<li>advanced HER2-negative gastric\/gastroesophageal junction adenocarcinoma (<a href=\"https:\/\/cslide.ctimeetingtech.com\/asia2023\/attendee\/confcal\/presentation\/list?q=138MO\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">138MO<\/a> \u2013 KEYNOTE-859, Asia subgroup analysis)<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>The results of the studies presented at the congress will be published online as a supplement to <em>Annals of Oncology<\/em>. The abstract titles can be viewed through the online programme.<\/p>\n<h3>Press accreditation<\/h3>\n<p>ESMO welcomes press representatives working for recognised press outlets interested in obtaining information and reporting on cancer issues, upon presentation of a letter of assignment and a valid press card. Press representatives are required to observe and abide by the <a href=\"https:\/\/www.esmo.org\/newsroom\/press-and-media-policies\/esmo-policy-on-press-activities\" class>ESMO Policy on Press Activities<\/a>. To apply for press accreditation, please fill out the form available <a href=\"https:\/\/press-portal.esmo.org\/#\/accreditation?meeting=7359&amp;callbackUrl=https:\/\/www.esmo.org\/newsroom\/esmo-press-office\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">here<\/a>.&nbsp; Requests for press accreditation should be sent by Thursday, 30 November. Please, be kindly informed that onsite press accreditations <strong>will not<\/strong> be available.<\/p>\n<h3>Further information<\/h3>\n<p>ESMO Press Office<br \/><a href=\"mailto:press@esmo.org\" class>press@esmo.org<\/a><\/p>\n<h3>Notes to editor&nbsp;&nbsp;<\/h3>\n<p>Please make sure to use the official name of the meeting in your reports: \u202f<strong>ESMO Asia Congress 2023<\/strong>\u202fand the official congress hashtag \u202f<strong>#ESMOAsia23<\/strong>.&nbsp;Follow it to stay up to date and use it to take part in the conversation on \u202f<a href=\"https:\/\/twitter.com\/myESMO?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"https:\/\/twitter.com\/myesmo?ref_src=twsrc%5egoogle%7ctwcamp%5eserp%7ctwgr%5eauthor\" class=\"external-link\">X (Twitter)<\/a>, \u202f<a href=\"https:\/\/www.linkedin.com\/company\/european-society-for-medical-oncology\/\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"https:\/\/www.linkedin.com\/company\/european-society-for-medical-oncology\/\" class=\"external-link\">LinkedIn<\/a>, \u202f<a href=\"https:\/\/www.instagram.com\/esmo_eur_oncology\/\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"https:\/\/www.instagram.com\/esmo_eur_oncology\/\" class=\"external-link\">Instagram<\/a>, \u202f<a href=\"https:\/\/www.facebook.com\/esmo.org\/\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"https:\/\/www.facebook.com\/esmo.org\/\" class=\"external-link\">Facebook<\/a><\/p>\n<p><a href=\"https:\/\/www.esmo.org\/newsroom\/press-releases\/esmo-asia-congress-2023-1-3-december-2023-singapore\">Source<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>LUGANO, Switzerland \u2013 The&nbsp;ESMO Asia Congress 2023&nbsp;is the annual meeting to present and discuss the latest scientific and clinical advances across the entire field of oncology, of relevance at a global level and specifically for the Asia-Pacific region. The event will be held in person in Singapore from 1 to 3 December 2023. Distinguished international [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[5137],"tags":[],"class_list":["post-46344","post","type-post","status-publish","format-standard","hentry","category-world-news"],"_links":{"self":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/46344","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/comments?post=46344"}],"version-history":[{"count":1,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/46344\/revisions"}],"predecessor-version":[{"id":46371,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/46344\/revisions\/46371"}],"wp:attachment":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/media?parent=46344"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/categories?post=46344"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/tags?post=46344"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}